Background {#Sec1}
==========

Over the last decade, basic scientific research has led to a greater understanding of the contribution made by genes to present and future health (Guttmacher and Collins [@CR13]). It is increasingly recognised that genetic information will need to be integrated into all aspects of health care delivery, including primary care (Department of Health [@CR9]; Greendale and Pyeritz [@CR12]; Harris and Harris [@CR14]). Patient advocacy groups have lobbied to raise health professionals' awareness of genetic issues (World Alliance of Organizations for the Prevention of Birth Defects [@CR36]), and the need for both patients and professionals to have an appropriate level of familiarity with the new technologies has been recognised by the European Commission (McNally et al. [@CR22]).

Primary care providers have varying levels of involvement and confidence in genetics (Emery et al. [@CR11]). We have demonstrated variable quality care provided for genetic conditions by non-geneticists (Harris et al. [@CR15]). This has also been reported in Australia (Tyzack and Wallace [@CR31]), the Netherlands (Baars et al. [@CR1]; van Langen et al. [@CR32]), Singapore (Yong et al. [@CR37]), and USA (Barrison et al. [@CR2]; Batra et al. [@CR3]; Schroy et al. [@CR29]; Taylor [@CR30]). Core competencies for all health professionals and particular professional groups are being developed by expert panels (Calzone et al. [@CR5]; Core Competency Working Group of the National Coalition for Health Professional Education in Genetics [@CR8]; Kirk et al. [@CR20]), and we have recently reported the educational priorities of the healthcare providers themselves (Julian-Reynier et al. [@CR19]). A multiplicity of structures and organisations are involved in training health professionals in genetics (Challen et al. [@CR7], [@CR6]; Henriksson and Kristoffersson [@CR16]; Julian-Reynier and Arnaud [@CR18]; Plass et al. [@CR25]; Schmidtke et al. [@CR28]). As part of a larger study in five European countries, we examined the self-reported behaviours and educational priorities of primary care providers in situations where genetics was relevant. This paper will present the results relating to perceptions of professional responsibility for genetic care amongst general practitioners, using hereditary cardiac disease as an example of the "new" genetics in common diseases. We aimed to analyse these attitudes and their determining factors.

Methods {#Sec2}
=======

Sampling {#Sec3}
--------

As part of the larger GenEd (Genetic Education for Nongenetic Health Professionals) study into educational priorities in genetics for primary care providers, general practitioners in France, Germany, Netherlands, Sweden and UK were sent a self-administered questionnaire in early 2005. The sample size was calculated based on a 10% precision (95% CI) for an educational outcome measure (Calefato et al. [@CR4]). Germany used a deliberate over-sampling strategy because of the anticipated low response rate. In France and UK, a random sample of a representative database was taken, in Germany a random sample of MDs receiving reimbursement from sickness funds and training MD students was taken, in the Netherlands sampling was undertaken by the Netherlands Institute for Health Services Research excluding those who had recently participated in research and Sweden all general practitioners were approached. Non-responders were sent at least one reminder letter and, in some countries, were telephoned.

Questionnaire {#Sec4}
-------------

The questionnaire was developed by a multidisciplinary group including geneticists, primary care providers and statisticians, initially in English. It was piloted in English in each participating country, then translated and back-translated to ensure consistency. Translated questionnaires were then re-piloted. As well as demographics, the questionnaire included a hypothetical scenario relating to sudden cardiac death, a diagnosis chosen because of the increasing recognition of genetic factors in its aetiology (as demonstrated by its inclusion in the 2005 revision of the UK National Service Framework for Heart Disease (Department of Health [@CR10])), but where "traditional" genetic teaching is unlikely to have featured. The text is shown in the text box. The vignette may have provided new information to some respondents. We wished to standardise their knowledge in order to interpret their subsequent practice intentions, as we intended the survey to be a pragmatic study of usual practice rather than a specific test of knowledge of HOCM. Box: text of the questionnaire scenarioMr Smith (aged 35) attends your surgery because his 27-year-old brother, a competitive swimmer, has just died suddenly. He collapsed in the pool and despite defibrillation was found to be dead. Although sudden death might not immediately suggest a genetic condition Mr Smith is worried because his mother's sister died suddenly aged 30 and he asks whether the same may happened to him, his children Melanie (12 years), and Tom (6 months) or his brother (32) or sister (24).He has been told that his brother's post-mortem demonstrated hypertrophic obstructive cardiomyopathy (HCM), which can be inherited as an autosomal dominant condition. 80% of non-traumatic sudden deaths in young athletes are due to inherited or congenital cardiovascular abnormalities and HCM accounts for 40--50% of these. Genetic testing may lead to identification of patients at high risk for sudden death as early as 10 years of age. Treatment can be considered with implantable defibrillators or medication.

Respondents were asked who, in the scenario, should perform the following tasks, with options being "myself without seeking further information", "myself after consulting a journal or the web", "myself after consulting a colleague", "a genetic specialist", "a cardiologist": Taking a family historyExplaining the inheritance patternExplaining the risk to the patient's childrenGiving information about available gene testsInforming the patient of the implications if no mutation were to be foundInforming the patient of the implications if a mutation were to be foundOrdering the genetic testExplaining the test resultExplaining the implications of the test result for the patient's children

Statistical analysis {#Sec5}
--------------------

Responses were entered into an SPSS v11.0 data sheet using SNAP v7.0 questionnaire and scanning software. For each task addressed in the questionnaire, the five possible responses were dichotomised into "likely to do oneself" and "should be done by a different professional". Univariate analysis was carried out for all tasks for association with: country of practice, gender, age (over/under 50 years), years in practice (under 10, 11--20, over 20), highest level of education in genetics, and usefulness or otherwise of continuing medical education, specialist training and undergraduate training. Factors found to be predictive at univariate analysis of "likely to do oneself" were entered into multivariate stepwise logistic regression analysis using a forward procedure (Wald test) (Hosmer and Lemeshow [@CR17]). A type 1 error of \<0.05 was chosen for the variables to be included in the final model.

Ethics {#Sec6}
------

Ethical approval was provided by the Eastern MREC (UK) and appropriate approval was obtained in all countries.

Results {#Sec7}
=======

Overall, 1,168 (28.6%) practitioners responded (France 236 (48.7%), Germany 251 (20.8%), Netherlands 254 (37%), Sweden 262 (38.7%), UK 165 (23.1%)). Demographics of respondents are shown in Table [1](#Tab1){ref-type="table"}. The highest level of genetic education varied significantly (*p* \< 0.05) between countries; rates of receiving relevant undergraduate education were: Sweden 90%, UK 65%, Germany 60%, Netherlands 57% and France 50%. The highest level of genetic education was also significantly associated with years spent in practice (Table [2](#Tab2){ref-type="table"}; *χ*^2^ = 84.578, df = 8, *p* \< 0.001). Table 1Demographics of respondents (*n* varies due to incomplete responses)CharacteristicNumber (percentage)Country of practice France236 (20.2) Germany251 (21.5) Netherlands254 (21.7) Sweden262 (22.4) UK165 (14.1)Gender Male764 (65.4) Female404 (34.6)Age group ≤50 years572 (49.0) \>50 years596 (51.0)Years in practice ≤10182 (15.6) 11--20466 (39.9) \>20520 (44.5)Patients seen per week \<2533 (2.9) 26--50133 (11.5) 51--100358 (31.0) 101--150309 (26.8) 151--200199 (17.2) \>200122 (10.6)Highest level of education in genetics None224 (19.2) Undergraduate680 (58.2) During specialist training53 (4.5) CME172 (14.7) Further degree32 (2.7) Missing7 (0.6)Value of undergraduate training (*n* = 880) Useful538 (61.1) Useless342 (38.9)Value of specialist training (*n* = 71) Useful61 (85.9) Useless10 (14.1)Value of CME (*n* = 172) Useful164 (95.3) Useless8 (4.7)Table 2Highest level of education by years in practiceUndergraduateSpecialistCMEDegreeNoneTotal≤10 years130161941218111--20 years30918601065462\>20 years241199318147518Total68053172322241161

Numbers of respondents willing to carry out each of the tasks themselves is shown in Table [3](#Tab3){ref-type="table"}. Most (61%) expected to take a family history, and a significant minority (38%) were willing to explain an inheritance pattern. However, only 10.3 (28%) were willing to carry out any other tasks. Univariate analysis of factors predicting likelihood of carrying out tasks oneself is shown in Table [4](#Tab4){ref-type="table"}. Factors which remained significant at multivariate analysis are shown in Table [5](#Tab5){ref-type="table"}. Only country of practice and gender were consistently predictive of willingness to carry out more complex tasks, with French/German and male GPs showing more willingness. Table 3Willingness to carry out tasks oneselfTaskNumber willing to perform taskPercentageTaking a family history71761.4Explaining the inheritance pattern44538.1Explaining the genetic risk to Mr Smith's children32728Giving information about available genetic tests25822.1Informing Mr Smith of the implications of no mutation being found31627.1Informing Mr Smith of the implications of a mutation being found16914.5Ordering the genetic test18315.7Explaining the test results12911Explaining the implications of the test results for Mr Smith's children12010.3Table 4Univariate analysisTaskVariableOdds ratio for doing oneself (95% CI)Taking a family historyCountry (reference UK) France0.59 (0.39--0.90) Germany2.07 (1.33--3.23) Netherlands0.20 (0.13--0.30) Sweden2.41 (1.54--3.79)Gender (reference male) Female1.25 (0.98--1.61)Age (reference \>50) ≤500.73 (0.57--0.92)Years in practice (reference \>20) 11--200.90 (0.69--1.16) ≤100.93 (0.66--1.32)Highest genetic education (reference none) Undergraduate1.45 (1.07--1.98) During specialist training1.67 (0.88--3.18) CME0.52 (0.35--0.78)Value of genetic education (reference useless) Useful undergraduate0.96 (0.72--1.27) Useful specialist0.41 (0.08--2.12) Useful CME0.23 (0.05--1.18)Explaining the inheritance patternCountry (reference UK) France1.91 (1.26--2.89) Germany1.31 (0.87--1.98) Netherlands0.91 (0.59--1.38) Sweden1.48 (0.98--2.23)Gender (reference male) Female1.05 (0.82--1.35)Age (reference \>50) ≤501.44 (1.14--1.83)Years in practice (reference \>20) 11--201.40 (1.08--1.81) ≤101.23 (0.87--1.74)Highest genetic education (reference none) Undergraduate1.48 (1.07--2.04) During specialist training1.96 (1.07--3.61) CME1.09 (0.71--1.67)Value of genetic education (reference useless) Useful undergraduate1.55 (1.17--2.05) Useful specialist1.45 (0.37--5.66) Useful CME0.84 (0.19--3.65)Explaining the risk to Mr Smith's childrenCountry (reference UK) France2.95 (1.85--4.70) Germany1.64 (1.02--2.63) Netherlands1.31 (0.81--2.13) Sweden1.38 (0.85--2.21)Gender (reference male) Female0.64 (0.48--0.84)Age (reference \>50)≤501.20 (0.93--1.55)Years in practice (reference \>20) 11--201.03 (0.78--1.36) ≤100.89 (0.61--1.31)Highest genetic education (reference none) Undergraduate1.05 (0.75--1.47) During specialist training1.49 (0.79--2.81) CME0.89 (0.57--1.40)Value of genetic education (reference useless) Useful undergraduate1.50 (1.10--2.05) Useful specialist training1.62 (0.38--6.88) Useful CME0.56 (0.13--2.43)Giving information about available gene testsCountry (reference UK) France2.17 (1.30--3.63) Germany1.84 (1.10--3.07) Netherlands1.27 (0.75--2.16) Sweden1.59 (0.95--2.67)Gender (reference male) Female0.63 (0.46--0.85)Age (reference \>50) ≤500.69 (0.52--0.91)Years in practice (reference \>20) 11--200.79 (0.59--1.07) ≤100.56 (0.36--0.88)Highest genetic education (reference none) Undergraduate0.87 (0.61--1.24) During specialist training1.10 (0.56--2.18) CME0.73 (0.45--1.19)Value of genetic education (reference useless) Useful undergraduate1.48 (1.05--2.09) Useful specialist training3.77 (0.44--31.96) Useful CME0.73 (0.14--3.77)Informing Mr Smith of the implications if no mutation were to be foundCountry (reference UK) France4.01 (1.82--8.80) Germany23.97 (11.29--50.87) Netherlands7.76 (3.63--16.62) Sweden5.58 (2.59--12.03)Gender (reference male) Female0.58 (0.43--0.77)Age (reference \>50) ≤501.06 (0.82--1.37)Years in practice (reference \>20) 11--201.02 (0.78--1.35) ≤100.65 (0.43--0.98)Highest genetic education (reference none) Undergraduate0.99 (0.71--1.40) During specialist training1.53 (0.81--2.88) CME1.09 (0.70--1.70)Value of genetic education (reference useless) Useful undergraduate1.27 (0.93--1.74) Useful specialist training0.68 (0.17--2.69) Useful CME0.61 (0.14--2.66)Informing Mr Smith of the implications if a mutation were to be foundCountry (reference UK) France4.46 (1.83--10.89) Germany8.51 (3.58--20.20) Netherlands3.42 (1.39--8.42) Sweden4.64 (1.92--11.21)Gender (reference male) Female0.52 (0.36--0.76)Age (reference \>50) ≤500.85 (0.61--1.18)Years in practice (reference \>20) 11--200.84 (0.60--1.18) ≤100.56 (0.33--0.96)Highest genetic education (reference none) Undergraduate1.32 (0.84--2.07) During specialist training1.49 (0.66--3.40) CME1.18 (0.66--2.13)Value of genetic education (reference useless) Useful undergraduate1.36 (0.92--2.01) Useful specialist training1.77 (0.20--15.52) Useful CME0.23 (0.05--1.04)Ordering the genetic testCountry (reference UK) France2.16 (1.11--4.20) Germany3.33 (1.76--6.33) Netherlands1.76 (0.90--3.46) Sweden2.25 (1.17--4.33)Gender (reference male) Female0.62 (0.43--0.88)Age (reference \>50) ≤500.85 (0.62--1.17)Years in practice (reference \>20) 11--200.94 (0.67--1.32) ≤100.72 (0.44--1.19)Highest genetic education (reference none) Undergraduate1.24 (0.80--1.90) During specialist training0.92 (0.38--20.23) CME1.15 (0.66--2.02)Value of genetic education (reference useless) Useful undergraduate1.29 (0.88--1.87) Useful specialist training0.35 (0.08--1.65) Useful CME0.55 (0.11--2.89)Explaining the test resultCountry (reference UK) France5.45 (1.87--15.87) Germany10.24 (3.62--28.95) Netherlands3.55 (1.20--10.56) Sweden4.12 (1.41--12.08)Gender (reference male) Female0.36 (0.22--0.57)Age (reference \>50) ≤500.73 (0.51--1.06)Years in practice (reference \>20) 11--200.86 (0.58--1.28) ≤100.68 (0.38--1.22)Highest genetic education (reference none) Undergraduate1.47 (0.88--2.45) During specialist training0.80 (0.26--2.46) CME0.90 (0.44--1.83)Value of genetic education (reference useless) Useful undergraduate1.05 (0.69--1.60) Useful specialist trainingNA Useful CME0.25 (0.05--1.35)Explaining the implications of the test result for the childrenCountry (reference UK) France10.58 (2.48--45.19) Germany16.52 (3.94--69.25) Netherlands9.05 (2.12--38.70) Sweden7.21 (1.67--31.09)Gender (reference male) Female0.47 (0.30--0.74)Age (reference \>50) ≤500.81 (0.56--1.19)Years in practice (reference \>20) 11--200.87 (0.58--1.31) ≤100.82 (0.46--1.44)Highest genetic education (reference none) Undergraduate1.05 (0.64--1.73) During specialist training0.88 (0.32--2.43) CME0.84 (0.42--1.66)Value of genetic education (reference useless) Useful undergraduate1.30 (0.83--2.06) Useful specialist training0.98 (0.11--9.14) Useful CME0.69 (0.08--5.98)Table 5Multivariate analysisTaskFactors predictive of doing it oneselfWald score*P*Taking a family historyCountry193.05\<0.005Explaining the inheritance patternCountry25.68\<0.005Age7.120.008Quality of undergraduate education12.60\<0.005Explaining the risk to Mr Smith's childrenCountry24.04\<0.005Quality of undergraduate education7.120.008Giving information about available gene testsQuality of undergraduate education6.290.012Gender4.590.032Age6.400.011Informing Mr Smith of the implications if no mutation were to be foundCountry93.09\<0.005Gender6.160.013Informing Mr Smith of the implications if a mutation were to be foundCountry31.02\<0.005Gender9.510.002Ordering the genetic testCountry15.070.005Gender7.220.007Explaining the test resultCountry29.24\<0.005Gender15.05\<0.005Explaining the implications of the test result for the childrenCountry19.510.001Gender7.930.005

Discussion {#Sec8}
==========

Although most GPs (over 60%) would consider it part of their role to take a family history, far fewer (less than 25%) would be willing to discuss specific genetic tests or their implications. Taking a family history is generally considered essential for the appropriate management of genetic disorders. Thirty-eight per cent of GPs in this study felt that this should be carried out by a specialist (either a geneticist or a cardiologist).

The country of practice was the only consistent predictor of GPs carrying out tasks themselves (with or without reference to a textbook, the web or a colleague), with French and German practitioners being more likely to do so. There appear to be two different patterns: German, Swedish and UK GPs were more likely to undertake initial tasks (particularly taking a family history), with lessening likelihood as the tasks became more complex, while French and Dutch GPs tended either to carry out a significant number of tasks or complete none and refer for the entire genetic care "package". It is unclear whether this reflects varying awareness or availability of specialist genetic services or varying willingness to refer to those services. It is likely that the health service model in each country will affect practitioners' expectations of managing the patient themselves or performing a gatekeeper role for secondary care. It may also be that varying health service structures restrict the availability of specific tests to non-specialist practitioners.

At least 50% of GPs recalled receiving undergraduate genetic education but this varied between countries. However, less than 10% recalled receiving genetic education during specialist training or continuing medical education, suggesting that any formal genetic education they had received was unlikely to have been up-to-date or clinically relevant. We could hypothesise that the counterintuitive finding (see Table [2](#Tab2){ref-type="table"}) of those practitioners who had been practising longer having received more post-specialist training in genetics represents a "catch-up" phenomenon; those practitioners trained more recently received the same information during undergraduate or specialist training. The perceived usefulness of genetic education as an undergraduate was a positive predictor of likelihood to explain inheritance patterns, risks and gene tests. This may reflect increased comfort in discussing genetic issues amongst those practitioners who underwent early engagement with genetics.

Being male appeared to increase the likelihood of carrying out many genetic tasks, particularly the more complex ones. There are several possible contributors to this finding. The tasks we assessed were primarily biomedical, and significant literature demonstrates the tendency of male physicians to communicate biomedical rather than psychosocial information (Roter et al. [@CR26]). Also, the self-reporting nature of this study may be affected by the tendency of female physicians to under-rate their own competence (Nomura et al. [@CR24]).

This is to our knowledge the first study in Europe of primary care providers' attitudes to genetic management and how they relate to genetic education. Although the response rate was not high, this is a common problem for postal surveys and all appropriate methods were used to increase the response rates. Databases from which samples were taken varied slightly between countries, but represented the only available national sources with doctors' addresses and specialties. We recognise that we have studied self-reported rather than actual behaviour but analysis of actual behaviour would have been impossible to be organised practically and self-reporting can be considered as a reliable proxy measure. Although the scenario used related only to one condition, sudden death from hypertrophic cardiomyopathy was selected as a scenario diagnosis specifically because it was unlikely to have featured in traditional Mendelian genetics teaching. The importance of genetics in its aetiology is, however, well recognised. We therefore suggest that it is likely to be a good model for common complex disorders with genetic aetiology encountered by primary care providers.

We have previously demonstrated that genetic care by non-geneticists is patchy and often poorly documented (Lane et al. [@CR21]; Williamson et al. [@CR35]; Williamson et al. [@CR33], [@CR34]). This is supported by qualitative research which found highly variable levels of information around referral and testing for Factor V Leiden (Saukko et al. [@CR27]) and multiple potential barriers to effective communication amongst GPs providing antenatal counselling (Nagle et al. [@CR23]). Our work shows clearly that, apart from family history taking, many European GPs do not consider that "genetic" care should form part of their practice.

Conclusions {#Sec9}
===========

It is clear that given the significant effect of country of practice, independent of all other factors, on practitioner behaviour, recommendations on genetic education at all levels will have to be sensitive to country-specific issues. Educational structures and content will require tailoring to local priorities and learning conventions. Any standards of care for non-genetic specialists providing some aspects of genetic care will need to be appropriately contextualised into the local system of health care and health education and it is unlikely that a pan-European "one size fits all" policy will be immediately workable or acceptable.
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